← Back to Search

SIGNAL for Ovarian Cancer (SIGNAL Trial)

N/A
Waitlist Available
Led By Alexi A. Wright, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

SIGNAL Trial Summary

This trial is testing whether a smartphone app can detect changes in behavior that may indicate cancer progression in patients with gynecological cancers.

Eligible Conditions
  • Ovarian Cancer
  • Peritoneal Carcinoma
  • Uterine Cancer
  • Cervical Cancer
  • Gynecologic Cancers

SIGNAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Burden rate
Rate of completion
Rate of enrollment

SIGNAL Trial Design

1Treatment groups
Experimental Treatment
Group I: SIGNALExperimental Treatment1 Intervention
Program to explore the feasibility and acceptability of a smartphone-based real-time behavioral anomaly detection system (SIGNAL). Patients will download the adapted Beiwe app onto their smartphones for a 6-month period and investigators will collect passive smartphone sensor data and active PRO data bi-weekly.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,078 Previous Clinical Trials
340,872 Total Patients Enrolled
39 Trials studying Ovarian Cancer
4,530 Patients Enrolled for Ovarian Cancer
National Institute of Nursing Research (NINR)NIH
577 Previous Clinical Trials
10,375,813 Total Patients Enrolled
1 Trials studying Ovarian Cancer
660 Patients Enrolled for Ovarian Cancer
Alexi A. Wright, MDPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
Alexi A. Wright 2022. "SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04368130.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top